Skip to main content
. Author manuscript; available in PMC: 2013 Apr 14.
Published in final edited form as: Crit Care Med. 2012 Mar;40(3):835–841. doi: 10.1097/CCM.0b013e318236f62d

Figure 3.

Figure 3

Increasing kynurenine/tryptophan ratios are associated with fewer delirium/coma-free days. Interpretative example: Other covariates being equal, patients with a kynurenine/tryptophan ratio at the 75th percentile (0.6 in this population) had an average of 2.1 fewer delirium/coma-free days than patients with a kynurenine/tryptophan ratio at the 25th percentile (0.1).